Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey
International Journal of Neonatal Screening · 11.03.2024 · 10 (1) · 23
DOI: 10.3390/ijns10010023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 11.03.2024. Verfasst von Kiran Moti Belaramani und 27 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Medicine Unit, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Newborn screening (NBS) is an important public health program that aims to identify pre-symptomatic healthy babies that will develop significant disease if left undiagnosed and untreated. The number of conditions being screened globally is expanding rapidly in parallel with advances in technology, diagnosis, and treatment availability for these conditions. In Hong Kong, NBS for inborn errors of metabolism (NBSIEM) began as a pilot program in October 2015 and was implemented to all birthing hospitals within the public healthcare system in phases, with completion in October 2020. The number of conditions screened for increased from 21 to 24 in April 2016 and then to 26 in October 2019. The overall recruitment rate of the NBS program was 99.5%. In the period between October 2015 and December 2022, 125,688 newborns were screened and 295 were referred back for abnormal results. The recall rate was reduced from 0.26% to 0.12% after the implementation of second-tier testing. An inherited metabolic disorder (IMD) was eventually confirmed in 47 infants, making the prevalence of IMD in Hong Kong 1 in 2674. At the time of the NBS result, 78.7% of the newborns with IMD were asymptomatic. There were two deaths reported: one newborn with methylmalonic acidemia cobalamin B type (MMACblB) died after the initial crisis and another case of carnitine palmitoyltransferase II deficiency (CPTII) died at 18 months of age after metabolic decompensation. The most common IMD noted were disorders of fatty acid oxidation metabolism (40%, 19 cases), closely followed by disorders of amino acid metabolism (38%, 18 cases), with carnitine uptake defect (19.1%, 9 cases) and citrullinemia type II (17%, 8 cases) being the two most common IMD picked up by the NBSIEM in Hong Kong. Out of the all the IMDs identified, 19.1% belonged to diverse ethnic groups. False negative cases were reported for citrullinemia type II and congenital adrenal hyperplasia during this period.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Metabolic Medicine Unit, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
- Newborn Screening Laboratory, Department of Pathology, Hong Kong Children's Hospital, Hong Kong, China.
- Clinical Genetics Service Unit, Hong Kong Children's Hospital, Hong Kong, China.
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
- Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong, China.
- Department of Paediatrics and Adolescent Medicine, Queen Elizabeth Hospital, Hong Kong, China.
ORCID-Profile: Toby Chun Hei Chan, Anne Mei Kwun Kwok, Eric Kin Cheong Yau, Josephine Shuk Ching Chong, Chloe Miu Mak
Zitieren
APA
Belaramani, K. M., Chan, T. C. H., Hau, E. W. L., Yeung, M. C. W., Kwok, A. M. K., Lo, I. F. M., Law, T. H. F., Wu, H., Wong, S. S. N., Lam, S. W., Ha, G. H. Y., Lau, T. P. Y., Wong, T. K., Or, V. W. C., Wong, R. M. S., Ming, W. L., Chow, J. C. K., Yau, E. K. C., Fu, A., …, & Fung, C. W. (2024). Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey. International Journal of Neonatal Screening, 10(1), 23. https://doi.org/10.3390/ijns10010023
Vancouver
Belaramani KM, Chan TCH, Hau EWL, Yeung MCW, Kwok AMK, Lo IFM, et al. Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey. International Journal of Neonatal Screening. 2024;10(1):23. doi:10.3390/ijns10010023
BibTeX
@article{Belaramani2024,
author = {Belaramani, Kiran Moti and Chan, Toby Chun Hei and Hau, Edgar Wai Lok and Yeung, Matthew Chun Wing and Kwok, Anne Mei Kwun and Lo, Ivan Fai Man and Law, Terry Hiu Fung and Wu, Helen and Wong, Sheila Suet Na and Lam, Shirley Wai and Ha, Gladys Ha Yin and Lau, Toby Pui Yee and Wong, Tsz Ki and Or, Venus Wai Ching and Wong, Rosanna Ming Sum and Ming, Wong Lap and Chow, Jasmine Chi Kwan and Yau, Eric Kin Cheong and Fu, Antony and Chong, Josephine Shuk Ching and Yau, Ho Chung and Poon, Grace Wing Kit and Ng, Kwok Leung and Chan, Kwong Tat and Lam, Yuen Yu and Hui, Joannie and Mak, Chloe Miu and Fung, Cheuk Wing},
title = {Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey},
journal = {International Journal of Neonatal Screening},
year = {2024},
volume = {10},
number = {1},
pages = {23},
doi = {10.3390/ijns10010023}
}
EUVIMED